Technical Analysis for HOTH - Hoth Therapeutics, Inc.

Grade Last Price % Change Price Change
F 1.46 -7.59% -0.12
HOTH closed down 7.59 percent on Monday, April 19, 2021, on 25 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical HOTH trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -7.59%
Hammer Candlestick Bullish -7.59%
New 52 Week Low Weakness -7.59%
Older End-of-Day Signals for HOTH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 10% about 18 hours ago
Fell Below Lower Bollinger Band about 18 hours ago
Down 5% about 20 hours ago
Down 3% about 20 hours ago
Fell Below Previous Day's Low about 20 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Hoth Therapeutics, Inc. Description

Hoth Therapeutics Inc., a Nevada corporation, is a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. Hoth has exclusive worldwide rights to the BioLexa Platform. Hoth intends to use the BioLexa Platform to develop two different topical cream products: (i) a product to treat eczema and (ii) a product that reduces post-procedure infections, accelerates healing and improves clinical outcomes for patients undergoing aesthetic dermatology procedures. Hoth’s initial focus will be on the development of the BioLexa Platform for the treatment of eczema. Eczema is a disease that results in inflammation of the skin and is characterized by rash, red skin, and itchiness. Eczema is also referred to as atopic dermatitis.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Immunology Disease Inflammation Dermatology Dermatitis Healing Atopic Dermatitis Atopy Eczema Type I Hypersensitivity Itchiness Sodium Hypochlorite Washes

Is HOTH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 4.96
52 Week Low 1.41
Average Volume 4,392,382
200-Day Moving Average 2.16
50-Day Moving Average 2.14
20-Day Moving Average 1.92
10-Day Moving Average 1.73
Average True Range 0.18
ADX 23.22
+DI 21.28
-DI 28.37
Chandelier Exit (Long, 3 ATRs ) 2.60
Chandelier Exit (Short, 3 ATRs ) 1.96
Upper Bollinger Band 2.42
Lower Bollinger Band 1.42
Percent B (%b) 0.04
BandWidth 52.23
MACD Line -0.16
MACD Signal Line -0.12
MACD Histogram -0.0432
Fundamentals Value
Market Cap 19.62 Million
Num Shares 13.4 Million
EPS -0.49
Price-to-Earnings (P/E) Ratio -2.96
Price-to-Sales 0.00
Price-to-Book 4.42
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.73
Resistance 3 (R3) 1.74 1.67 1.69
Resistance 2 (R2) 1.67 1.60 1.66 1.67
Resistance 1 (R1) 1.56 1.56 1.53 1.55 1.65
Pivot Point 1.49 1.49 1.47 1.48 1.49
Support 1 (S1) 1.38 1.42 1.35 1.37 1.27
Support 2 (S2) 1.31 1.38 1.30 1.25
Support 3 (S3) 1.20 1.31 1.24
Support 4 (S4) 1.19